Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. Apontis Pharma AG
  6. Summary
    APPH   DE000A3CMGM5

APONTIS PHARMA AG

(APPH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
07/22/2021 07/23/2021 07/26/2021 07/27/2021 07/28/2021 Date
18.6(c) 19.15(c) 19.85(c) 19.5(c) 19.7(c) Last
105 514 500 5 600 150 Volume
-1.59% +2.96% +3.66% -1.76% +1.03% Change
More quotes
Estimated financial data (e)
Sales 2021 48,7 M 57,6 M 57,6 M
Net income 2021 2,90 M 3,43 M 3,43 M
Net cash position 2021 28,8 M 34,0 M 34,0 M
P/E ratio 2021 57,1x
Yield 2021 -
Sales 2022 57,8 M 68,4 M 68,4 M
Net income 2022 5,15 M 6,10 M 6,10 M
Net cash position 2022 28,9 M 34,2 M 34,2 M
P/E ratio 2022 32,3x
Yield 2022 -
Capitalization 167 M 198 M 198 M
EV / Sales 2021 2,85x
EV / Sales 2022 2,40x
Nbr of Employees 195
Free-Float -
More Financials
Company
Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about APONTIS PHARMA AG
01:33aAPONTIS PHARMA : reports accelerated growth in first half of 2021 - Single Pill ..
EQ
01:31aPRESS RELEASE : APONTIS PHARMA reports accelerated growth in first half of 2021 ..
DJ
07/12PRESS RELEASE : APONTIS PHARMA marks further success in the roll-out of Single P..
DJ
07/12APONTIS PHARMA : marks further success in the roll-out of Single Pill therapy
EQ
06/18PRESS RELEASE : APONTIS PHARMA AG: Initial studies confirm that the share has a ..
DJ
06/18APONTIS PHARMA AG : Initial studies confirm that the share has a price potential..
EQ
06/10PRESS RELEASE : APONTIS PHARMA AG: Post-Stabilisation disclosure - Partial exerc..
DJ
06/10APONTIS PHARMA AG : Post-Stabilisation disclosure - Partial exercise of the Gree..
EQ
06/10PRESS RELEASE : APONTIS PHARMA AG: Notification on the implementation of stabili..
DJ
06/10PRESS RELEASE : APONTIS PHARMA AG: Notification on -2-
DJ
06/10APONTIS PHARMA AG : Notification on the implementation of stabilization measures
EQ
05/28PRESS RELEASE : APONTIS PHARMA AG: Notification on the implementation of stabili..
DJ
05/28APONTIS PHARMA AG : Notification on the implementation of stabilization measures
EQ
05/20PRESS RELEASE : APONTIS PHARMA AG Trading Update: Strong revenues and earnings g..
DJ
05/20APONTIS PHARMA AG TRADING UPDATE : Strong revenues and earnings growth with Sing..
EQ
More news
News in other languages on APONTIS PHARMA AG
01:31aDGAP-NEWS : APONTIS PHARMA mit beschleunigtem Wachstum in H1 2021 - Umsatz mit S..
01:31aAPONTIS PHARMA mit beschleunigtem Wachstum in H1 2021 - Umsatz mit Single Pil..
07/12APONTIS PHARMA : feiert weiteren Erfolg in der Verbreitung der Single Pill-Thera..
07/12APONTIS PHARMA feiert weiteren Erfolg in der Verbreitung der Single Pill-Ther..
06/18APONTIS PHARMA AG : Initial-Studien bescheinigen der Aktie zwischen 77 % und 135..
More news
Chart APONTIS PHARMA AG
Duration : Period :
Apontis Pharma AG Technical Analysis Chart | APPH | DE000A3CMGM5 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 19,70 €
Average target price 36,00 €
Spread / Average Target 82,7%
EPS Revisions
Managers and Directors
Thomas Milz Chief Product Officer
Sector and Competitors
1st jan.Capi. (M$)
APONTIS PHARMA AG0.00%196
JOHNSON & JOHNSON9.71%454 682
ROCHE HOLDING AG11.50%329 752
PFIZER, INC.14.37%235 663
NOVARTIS AG-0.44%221 987
ELI LILLY AND COMPANY44.27%221 420